248 related articles for article (PubMed ID: 22272696)
21. PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer.
Guan H; Wan Y; Lan J; Wang Q; Wang Z; Li Y; Zheng J; Zhang X; Wang Z; Shen Y; Xie F
Sci Rep; 2016 Oct; 6():35651. PubMed ID: 27762298
[TBL] [Abstract][Full Text] [Related]
22. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
Feng X; Li B; Ye H; Long D
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):309-14. PubMed ID: 21633918
[TBL] [Abstract][Full Text] [Related]
23. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
[TBL] [Abstract][Full Text] [Related]
24. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
[TBL] [Abstract][Full Text] [Related]
25. CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Sharma S; Khosla R; David P; Rastogi A; Vyas A; Singh D; Bhardwaj A; Sahney A; Maiwall R; Sarin SK; Trehanpati N
Front Immunol; 2015; 6():49. PubMed ID: 25767469
[TBL] [Abstract][Full Text] [Related]
26. Increased infiltration of regulatory T cells in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant.
Teng CF; Li TC; Wang T; Liao DC; Wen YH; Wu TH; Wang J; Wu HC; Shyu WC; Su IJ; Jeng LB
Sci Rep; 2021 Jan; 11(1):1136. PubMed ID: 33441885
[TBL] [Abstract][Full Text] [Related]
27. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T cells are associated with post-cryoablation prognosis in patients with hepatitis B virus-related hepatocellular carcinoma.
Zhou L; Fu JL; Lu YY; Fu BY; Wang CP; An LJ; Wang XZ; Zeng Z; Zhou CB; Yang YP; Wang FS
J Gastroenterol; 2010 Sep; 45(9):968-78. PubMed ID: 20411280
[TBL] [Abstract][Full Text] [Related]
29. Defective Circulating Regulatory B Cells in Patients with Dilated Cardiomyopathy.
Jiao J; Lu YZ; Xia N; Wang YQ; Tang TT; Nie SF; Lv BJ; Wang KJ; Wen S; Li JY; Zhou XD; Liao YH; Cheng X
Cell Physiol Biochem; 2018; 46(1):23-35. PubMed ID: 29566367
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of regulatory T cells proportion in the peripheral blood and tumor tissue in primary hepatocellular carcinoma].
Li SP; Peng QQ; Ding T; Xu J; Zhang CQ; Feng KT; Li JQ
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):523-7. PubMed ID: 19062720
[TBL] [Abstract][Full Text] [Related]
31. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
[TBL] [Abstract][Full Text] [Related]
32. Increased IL-35 producing Tregs and CD19
Tarique M; Saini C; Naqvi RA; Khanna N; Rao DN
Cytokine; 2017 Mar; 91():82-88. PubMed ID: 28038394
[TBL] [Abstract][Full Text] [Related]
33. Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer.
Zhou J; Min Z; Zhang D; Wang W; Marincola F; Wang X
J Transl Med; 2014 Nov; 12():304. PubMed ID: 25381811
[TBL] [Abstract][Full Text] [Related]
34. Perioperative changes in peripheral regulatory B cells of patients with esophageal cancer.
Shi J; Li S; Zhou Y; Wang L; Wen J; Wang Y; Kang Z
Mol Med Rep; 2014 Sep; 10(3):1525-30. PubMed ID: 24969402
[TBL] [Abstract][Full Text] [Related]
35. Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma.
Song S; Yuan P; Li P; Wu H; Lu J; Wei W
Int Immunopharmacol; 2014 Oct; 22(2):392-9. PubMed ID: 25066760
[TBL] [Abstract][Full Text] [Related]
36. Immune Regulation by T Regulatory Cells in Hepatitis B Virus-Related Inflammation and Cancer.
Trehanpati N; Vyas AK
Scand J Immunol; 2017 Mar; 85(3):175-181. PubMed ID: 28109025
[TBL] [Abstract][Full Text] [Related]
37. Regulatory B Cells and Their Cytokine Profile in HCV-Related Hepatocellular Carcinoma: Association with Regulatory T Cells and Disease Progression.
Hetta HF; Mekky MA; Zahran AM; Abdel-Malek MO; Ramadan HK; Shafik EA; Abbas WA; Abbas El-Masry M; Mohamed NA; Kamel AA; Marraiki N; Beshbishy AM; Batiha GE; Osman HA; Koneru G; El-Mokhtar MA
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32664587
[TBL] [Abstract][Full Text] [Related]
38. Changes of CD4(+) CD25 (+) regulatory T cells in peripheral blood in patients with hepatocellular carcinoma before and after TACE.
Xiong B; Feng G; Luo S; Liang H; Qiu L; Zheng C; Liu X; Zhou G
J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):645-8. PubMed ID: 19107357
[TBL] [Abstract][Full Text] [Related]
39. Roles of Tregs in development of hepatocellular carcinoma: a meta-analysis.
Zhao HQ; Li WM; Lu ZQ; Yao YM
World J Gastroenterol; 2014 Jun; 20(24):7971-8. PubMed ID: 24976734
[TBL] [Abstract][Full Text] [Related]
40. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
